This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

Oral Epalrestat Therapy in Pediatric Subjects With PMM2-CDG

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04925960
Recruitment Status : Active, not recruiting
First Posted : June 14, 2021
Last Update Posted : January 11, 2024
Information provided by (Responsible Party):
Maggie's Pearl, LLC

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : February 28, 2024
Estimated Study Completion Date : December 31, 2025